Novel therapeutic modalities and drug delivery in pancreatic cancer – an ongoing search for improved efficacy
Pancreatic cancer is an incredibly challenging disease due to its high rates of resistance to traditional chemotherapy and radiotherapy. There has been little improvement in the prognosis of pancreatic cancer cases in the past decades, highlighting the crucial need for more effective therapeutic app...
Main Authors: | Yuqing Zhang, Kei Satoh, Min Li |
---|---|
Format: | Article |
Language: | English |
Published: |
BioExcel Publishing Ltd
2012-12-01
|
Series: | Drugs in Context |
Subjects: | |
Online Access: | http://drugsincontext.com/individual/novel-therapeutic-modalities-and-drug-delivery-in-pancreatic-cancer |
Similar Items
-
A streamlined method for the design and cloning of shRNAs into an optimized Dox-inducible lentiviral vector
by: Frank, Sander B., et al.
Published: (2017) -
Gene Mutation Analysis in EGFR Wild Type NSCLC Responsive to Erlotinib: Are There Features to Guide Patient Selection?
by: Paola Ulivi, et al.
Published: (2014-12-01) -
RNA Interference as a Prospective Tool for the Control of Human Viral Infections
by: Alesia Levanova, et al.
Published: (2018-09-01) -
Recent Findings Concerning PAMAM Dendrimer Conjugates with Cyclodextrins as Carriers of DNA and RNA
by: Keiichi Motoyama, et al.
Published: (2009-08-01) -
Deep Sequencing Insights in Therapeutic shRNA Processing and siRNA Target Cleavage Precision
by: Hubert Denise, et al.
Published: (2014-01-01)